Psoriasis Club
  • Forum
  • Home
  • Portal
  • Member List
  • Psoriasis Score
  • PQOLS
  • What is psoriasis
  • Search
  • Help
Hello Guest, Welcome To The Psoriasis Club Forum. We are a self funded friendly group of people who understand.
Never be alone with psoriasis, come and join us. (Members have more privileges)
wave
Login Register
Login
Username:
Password:
Lost Password?
 
Psoriasis Club › HealthHealth Boards › Psoriasis In The News v
1 2 3 4 5 … 49 Next »

Tapinarof gets FDA approval for psoriasis

Threaded Mode
Tapinarof gets FDA approval for psoriasis
Fred Online
I Wanted To Change the World But Got Up Far Too Late.
Moderator
Posts: 57,003
Threads: 3,553
Joined: Aug 2011
Gender: Male
Location: France
Psoriasis Score: 1
Psoriatic Arthritis Score: 1
PQOLS: 2
Treatment: Bimzelx / Coconut Oil
#1
News  Tue-24-05-2022, 14:43 PM
Following on from this thread Tapinarof for psoriasis phase 3 data Tapinarof (VTAMA) is now approved for use on psoriasis by the U.S. Food and Drug Administration (FDA)

Quote:
Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the U.S. Food and Drug Administration (FDA) has approved VTAMA® (tapinarof) cream, 1%, an aryl hydrocarbon receptor agonist, indicated for the topical treatment of plaque psoriasis in adults. This approval makes VTAMA cream the first and only FDA-approved steroid-free topical medication in its class.

“We are delighted with our FDA-approved label for VTAMA cream, which is for adults with psoriasis, regardless of disease severity, and with an unlimited duration of use. In anticipation of today’s approval, we have a fully built commercial infrastructure in place, and I am excited to say we will have product in the channel in the first week of June. As the first and only approved drug in its class in the U.S., the FDA’s approval of VTAMA cream provides an effective new non-steroidal treatment option for millions of adults living with plaque psoriasis and represents a major milestone for Dermavant and its stakeholders,” said Todd Zavodnick, Chief Executive Officer of Dermavant. “At Dermavant, we are committed to advancing novel, patient-focused innovation in immuno-dermatology. As such, we are proud to have developed a topical treatment in VTAMA cream that provides not only efficacy over 52 weeks but can also be used on all body areas, including on sensitive locations, such as face, skin folds, neck, genitalia, anal crux, inflammatory areas, and axillae. In addition, an approximately four month off-treatment remittive effect (median time to first worsening), leads us to believe that VTAMA cream has the potential to become the preferred topical option for this chronically underserved patient population and among the physicians who treat them.”

“Following 20-plus years of minimal innovation in the topical psoriasis treatment space, I believe the approval of VTAMA cream is an important step in establishing a new treatment option for adults with mild, moderate and severe plaque psoriasis ,” said Mark Lebwohl, MD, FAAD, Dean for Clinical Therapeutics and Waldman Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai in New York and lead author of the Phase 3 studies of VTAMA cream published in The New England Journal of Medicine. “As a clinician, I’m excited to finally have a versatile, once-daily, steroid-free topical treatment that is backed by extensive clinical trial data supporting its favorable safety and efficacy profile and a demonstrated remittive effect of approximately four months in patients off therapy.”

Across PSOARING 1 and PSOARING 2, VTAMA cream demonstrated highly statistically significant improvement in Physician Global Assessment (PGA) score of “clear” (PGA=0) or “almost clear” (PGA=1) with a minimum 2-grade improvement compared with vehicle from baseline at week 12. VTAMA cream also demonstrated a highly statistically significant improvement in all secondary endpoints versus vehicle, including ≥75% Improvement in Psoriasis Area and Severity Index (PASI) score (PASI-75) from baseline at week 12. The adverse event (AE) profile of VTAMA cream reported in both PSOARING 1 and PSOARING 2 demonstrated that the majority of AEs were localized to the site of application and were mild to moderate in nature. The most common AEs of subjects treated with VTAMA cream were folliculitis, nasopharyngitis, and contact dermatitis.

Source: dermavant.com
Quote
Caroline Online
You must hurry if you ever want to catch a chicken...
*
Forum Helper
Posts: 21,930
Threads: 105
Joined: Nov 2011
Gender: Female
Location: In between the tulips
Psoriasis Score: 3
Psoriatic Arthritis Score: 3
PQOLS: 4
Treatment: Got back to DMF slow release
#2
Tue-24-05-2022, 21:03 PM
Interesting, must be something alike the product Sorion. That is also without steroids.
Quote
KatT Offline
100 + Member I Just Cant Stop !

100 + Member I Just Cant Stop !
Posts: 5,775
Threads: 50
Joined: Sep 2019
Gender: Female
Location: Canada
Psoriasis Score: 1
Psoriatic Arthritis Score: Off the chart!
Treatment: Simponi + hydroxychloroquine + MTX
#3
Tue-24-05-2022, 22:52 PM
Very good!  A better option than steroids cream
Quote
Kat Offline
Take my advice; I don't use it anyway.
*
Forum Helper
Posts: 7,361
Threads: 45
Joined: Aug 2014
Gender: Female
Location: GA
Psoriasis Score: 8
Treatment: Moisturizers
#4
Tue-31-01-2023, 01:28 AM
Just saw an ad for this under the name Vtama (tapinaro)

Thinking of asking about this one since my psoriasis is mostly behind my ears and along my neck (and scalp). Well once I get back to seeing a dermatologist since I haven't been since pre covid. Same with rheumatologist. I thought I would wait till things settled down and now I have no excuse not to call them. Confused
Quote
Caroline Online
You must hurry if you ever want to catch a chicken...
*
Forum Helper
Posts: 21,930
Threads: 105
Joined: Nov 2011
Gender: Female
Location: In between the tulips
Psoriasis Score: 3
Psoriatic Arthritis Score: 3
PQOLS: 4
Treatment: Got back to DMF slow release
#5
Tue-31-01-2023, 08:03 AM
Always good to try a product like this Kat.
And indeed… no excuses anymore. Smile
Quote
Kat Offline
Take my advice; I don't use it anyway.
*
Forum Helper
Posts: 7,361
Threads: 45
Joined: Aug 2014
Gender: Female
Location: GA
Psoriasis Score: 8
Treatment: Moisturizers
#6
Tue-31-01-2023, 17:37 PM
(Tue-31-01-2023, 08:03 AM)Caroline Wrote: Always good to try a product like this Kat.
And indeed… no excuses anymore.  Smile

Yeah, I've been managing with OTC creams and Coconut oil. It all helps but I can't get past where I am right now and I'd really like to be a little less itchy. I figure less is best so I'll give it a try. Although I'll bet the rheumatologist wants me to do a biologic. We'll see.
Quote
Caroline Online
You must hurry if you ever want to catch a chicken...
*
Forum Helper
Posts: 21,930
Threads: 105
Joined: Nov 2011
Gender: Female
Location: In between the tulips
Psoriasis Score: 3
Psoriatic Arthritis Score: 3
PQOLS: 4
Treatment: Got back to DMF slow release
#7
Tue-31-01-2023, 18:41 PM
(Tue-31-01-2023, 17:37 PM)Kat Wrote:
(Tue-31-01-2023, 08:03 AM)Caroline Wrote: Always good to try a product like this Kat.
And indeed… no excuses anymore.  Smile

Yeah, I've been managing with OTC creams and Coconut oil.  It all helps but I can't get past where I am right now and I'd really like to be a little less itchy.  I figure less is best so I'll give it a try.  Although I'll bet the rheumatologist wants me to do a biologic. We'll see.

Well in the end it is your decision Kat… Smile It makes sense to first try something that might work and is not so heavy as a biologic.
Quote
« Next Oldest | Next Newest »


Possibly Related Threads…
Thread Author Replies Views Last Post
News Rinvoq goes for psoriatic arthritis approval Fred 12 5,156 Mon-17-01-2022, 21:12 PM
Last Post: jiml
News Cosentyx gets FDA approval for juvenile psoriatic arthritis Fred 1 1,308 Sun-26-12-2021, 21:04 PM
Last Post: Caroline
News Cosentyx gets NICE approval for use in children with psoriasis Fred 5 1,801 Sun-05-09-2021, 15:10 PM
Last Post: Caroline
News Cosentyx gets FDA approval for use in children with psoriasis Fred 0 727 Wed-02-06-2021, 09:48 AM
Last Post: Fred
News Tapinarof for psoriasis phase 3 data Fred 0 1,075 Sat-24-04-2021, 11:27 AM
Last Post: Fred



Users browsing this thread: 1 Guest(s)
    Contact us | Login | Register | Home | Cookies/GDPR | RSS Syndication | Portal | Types Of Psoriasis | Psoriasis Score | Members Only Boards
    Copyright © 2010 - 2023 Psoriasis Club All Rights Reserved | Founded May 2010 | Psoriasis Club Is Self Funded Without Sponsors Or Donations | Software by MyBB | Social
Linear Mode
Threaded Mode